Arnuity Ellipta 200mcg Oral Inh 14

Manufacturer GLAXO SMITH KLINE Active Ingredient Fluticasone Inhalation Powder(floo TIK a sone) Pronunciation AR-noo-ih-tee eh-LIP-tuh (Fluticasone: floo-TIK-a-sone)
It is used to treat asthma.Do not use this drug to treat an asthma attack. Use a rescue inhaler. Talk with your doctor.
🏷️
Drug Class
Inhaled Corticosteroid (ICS)
🧬
Pharmacologic Class
Glucocorticoid Receptor Agonist
🀰
Pregnancy Category
Not available
βœ…
FDA Approved
May 2014
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Arnuity Ellipta is an inhaled medicine that contains a corticosteroid called fluticasone furoate. It works by reducing inflammation in your lungs, which helps to prevent asthma symptoms like wheezing and shortness of breath. It is used once a day to help control your asthma over time, but it is NOT for sudden breathing problems.
πŸ“‹

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Continue taking this medication as directed by your doctor or healthcare provider, even if you feel well. Take this medication at the same time every day.

Important Administration Instructions

This medication is for inhalation only. Rinse your mouth with water after each use, but do not swallow the rinse water. Spit it out instead.
If you are using multiple inhaled medications, consult your doctor about which one to use first.
Only prepare a dose when you are ready to take it. If you prepare a dose and then close the inhaler without taking it, the medication will be wasted and the inhaler may be damaged.
Avoid breathing out into the inhaler. Close the inhaler after each use.
Do not disassemble the device or wash it. This medication should not be used with a spacer.
To clean the mouthpiece, gently wipe it with a dry tissue or cloth. Avoid washing or submerging it in water.

Storage and Disposal

Store this medication at room temperature in a dry place, away from bathrooms. Keep it in the foil packaging until you are ready to use it. Be aware of the expiration date or the number of days this brand of medication remains effective after opening the foil. Dispose of the inhaler after this period or when the dose counter reaches "0", whichever occurs first.

Missed Dose Instructions

If you miss a dose, skip it and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
πŸ’‘

Lifestyle & Tips

  • Use Arnuity Ellipta once daily, at the same time each day, as prescribed by your doctor. Do not use it more often than prescribed.
  • This medicine is not a rescue inhaler. Always carry a fast-acting rescue inhaler (like albuterol) for sudden breathing problems.
  • After each use, rinse your mouth with water and spit it out. Do not swallow the water. This helps prevent a fungal infection in your mouth and throat (thrush).
  • Do not stop using Arnuity Ellipta suddenly, even if you feel better, without talking to your doctor. Your asthma symptoms could worsen.
  • Learn the correct way to use the Ellipta inhaler device. Your doctor, pharmacist, or nurse can demonstrate.
  • Keep track of the number of doses remaining in your inhaler and refill your prescription before you run out.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 200 mcg once daily
Dose Range: 100 - 200 mg

Condition-Specific Dosing:

asthma: 100 mcg or 200 mcg once daily. Maximum 200 mcg once daily.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: 5-11 years: 50 mcg once daily.
Adolescent: >=12 years: 100 mcg or 200 mcg once daily.
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment necessary.
Moderate: No dosage adjustment necessary.
Severe: No dosage adjustment necessary.
Dialysis: No specific considerations; systemic exposure is minimal.

Hepatic Impairment:

Mild: No dosage adjustment necessary.
Moderate: No dosage adjustment necessary.
Severe: Use with caution; increased systemic exposure may occur. Monitor for corticosteroid effects.

Pharmacology

πŸ”¬

Mechanism of Action

Fluticasone furoate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. It binds to glucocorticoid receptors, inhibiting the release of inflammatory mediators (e.g., histamine, eicosanoids, leukotrienes, cytokines) and suppressing the migration of inflammatory cells (e.g., eosinophils, mast cells, lymphocytes, macrophages, neutrophils) to the site of inflammation. This reduces airway hyperresponsiveness and inflammation in the lungs.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: <1% (100 mcg dose), <2% (200 mcg dose) due to high first-pass metabolism and incomplete absorption.
Tmax: 0.5-1 hour
FoodEffect: Not applicable for inhaled administration.

Distribution:

Vd: 661 L
ProteinBinding: >99%
CnssPenetration: Limited

Elimination:

HalfLife: Approximately 24 hours
Clearance: Not readily quantifiable due to extensive first-pass metabolism and low systemic exposure.
ExcretionRoute: Primarily feces (approximately 90% as metabolites and unchanged drug); <1% renally.
Unchanged: Minimal systemic excretion of unchanged drug.
⏱️

Pharmacodynamics

OnsetOfAction: Within 24 hours; full therapeutic effect may take 1-2 weeks.
PeakEffect: 1-2 weeks of regular use.
DurationOfAction: 24 hours (allowing for once-daily dosing).

Safety & Warnings

⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of infection, including:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or changed sputum production
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Signs of a weak adrenal gland, such as:
+ Severe nausea or vomiting
+ Severe dizziness or fainting
+ Muscle weakness
+ Extreme fatigue
+ Mood changes
+ Decreased appetite
+ Weight loss
Signs of Cushing's syndrome, including:
+ Weight gain in the upper back or abdomen
+ Moon face
+ Severe headache
+ Slow wound healing
Symptoms of withdrawal or missed dose, such as:
+ Feeling extremely tired, weak, or irritable
+ Trembling
+ Rapid heartbeat
+ Confusion
+ Sweating
+ Dizziness
Other severe symptoms, including:
+ Flushing
+ Redness or white patches in the mouth or throat
+ Mouth irritation or sores
+ Bone or joint pain
+ Changes in vision
+ Changes in voice
+ Difficulty speaking

Respiratory Emergency

This medication can cause severe breathing problems, which may be life-threatening. If you experience trouble breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek medical help immediately.

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only mild ones, it's essential to discuss any concerns with your doctor. If you notice any of the following side effects or any other symptoms that bother you or don't go away, contact your doctor:

Signs of a common cold
Nose or throat irritation
Headache
Feeling tired or weak
Flu-like symptoms
Diarrhea
Upset stomach or nausea
Vomiting
* Muscle pain

Reporting Side Effects

This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening asthma symptoms (e.g., increased wheezing, shortness of breath, cough, or need for rescue inhaler)
  • Signs of oral thrush (white patches in your mouth or on your tongue)
  • Signs of allergic reaction (e.g., rash, hives, swelling of face/mouth/tongue, severe dizziness, trouble breathing)
  • Signs of infection (e.g., fever, chills, increased mucus, change in mucus color)
  • Vision changes (e.g., blurred vision, eye pain, halos around lights) - rare, but possible with long-term use
  • Unusual tiredness, weakness, nausea, vomiting, or dizziness (signs of adrenal insufficiency, especially if stopping suddenly after long-term high-dose use)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have a milk allergy, as this may be relevant to your treatment.
Any medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This is crucial because certain medications, such as those used to treat HIV, infections, depression, and other conditions, should not be taken with this drug. Your doctor or pharmacist can advise you on potential interactions.
Please note that this is not an exhaustive list of all medications or health conditions that may interact with this drug.

To ensure your safety, it is vital to discuss all of your medications (prescription and OTC), natural products, vitamins, and health problems with your doctor and pharmacist. This will help determine whether it is safe for you to take this medication in conjunction with your other treatments. Never start, stop, or change the dosage of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

Important Information About Your Medication

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Monitoring Your Condition

If your breathing problems worsen, your rescue inhaler is not effective, or you need to use it more frequently, contact your doctor immediately. It may take a few weeks to experience the full benefits of this medication. If you have been taking this medication for an extended period, consult your doctor before stopping, as you may need to gradually taper off the medication.

Infection Prevention

You may be more susceptible to infections while taking this medication. To minimize the risk, wash your hands frequently, avoid close contact with people who have infections, colds, or flu, and avoid exposure to chickenpox and measles if you have not had these illnesses before. If you have been exposed to chickenpox or measles, consult your doctor promptly.

Special Precautions

When transitioning from an oral steroid to another form of steroid, you may be at risk for severe and potentially life-threatening side effects, including weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar. If you experience any of these symptoms, contact your doctor immediately. Additionally, if you suffer a severe injury, undergo surgery, or develop an infection, you may require extra doses of oral steroids to help your body cope with the stress. Carry a warning card indicating that you may need additional steroids in certain situations.

Long-term Use and Potential Side Effects

Prolonged use of this medication may increase the risk of developing cataracts or glaucoma. Consult your doctor to discuss this potential risk and schedule regular eye pressure checks if you are taking this medication long-term. Furthermore, long-term use may also lead to osteoporosis (weak bones). Discuss your individual risk with your doctor and undergo bone density tests as recommended.

Special Considerations for Children

If you are a child or teenager taking this medication, your doctor will closely monitor you for potential side effects, which may be more likely to occur in younger patients. This medication may affect growth in some cases, and regular growth checks may be necessary.

Pregnancy and Breastfeeding

If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor to discuss the potential benefits and risks of this medication to you and your baby.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Acute overdose is unlikely due to low systemic absorption. Chronic overdose may lead to signs of hypercorticism (e.g., Cushing's syndrome) and adrenal suppression.

What to Do:

Seek immediate medical attention or call a poison control center (e.g., 1-800-222-1222). Management is supportive. Chronic overdose may require gradual withdrawal of the corticosteroid under medical supervision.

Drug Interactions

πŸ”΄

Major Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, cobicistat): May significantly increase systemic fluticasone furoate exposure, leading to increased risk of systemic corticosteroid effects (e.g., Cushing's syndrome, adrenal suppression).
🟑

Moderate Interactions

  • Moderate CYP3A4 inhibitors (e.g., erythromycin, diltiazem): Potential for increased systemic exposure, but less pronounced than with strong inhibitors. Monitor for systemic corticosteroid effects.

Monitoring

πŸ”¬

Baseline Monitoring

Pulmonary function tests (e.g., FEV1)

Rationale: To establish baseline lung function and assess disease severity.

Timing: Prior to initiation of therapy.

Growth monitoring (in pediatric patients)

Rationale: Inhaled corticosteroids can potentially affect growth velocity in children.

Timing: Prior to initiation and regularly during therapy.

πŸ“Š

Routine Monitoring

Pulmonary function tests (e.g., FEV1)

Frequency: Periodically (e.g., every 3-6 months or as clinically indicated)

Target: Improvement towards patient's personal best or predicted normal values.

Action Threshold: Lack of improvement or worsening of lung function may indicate need for dose adjustment or alternative therapy.

Symptoms of asthma control (e.g., frequency of rescue inhaler use, nocturnal awakenings, activity limitation)

Frequency: Regularly (e.g., at each follow-up visit)

Target: Minimal symptoms, infrequent rescue inhaler use.

Action Threshold: Persistent or worsening symptoms may indicate inadequate control or need for dose adjustment.

Signs of oral candidiasis (thrush)

Frequency: At each follow-up visit

Target: Absence of white patches in mouth/throat.

Action Threshold: Presence of candidiasis requires antifungal treatment and reinforcement of proper rinsing technique.

Growth velocity (in pediatric patients)

Frequency: Every 3-6 months

Target: Normal growth velocity for age.

Action Threshold: Significant reduction in growth velocity may warrant re-evaluation of therapy.

Ocular examination (for long-term, high-dose use)

Frequency: Annually or as clinically indicated

Target: Absence of cataracts or glaucoma.

Action Threshold: Development of cataracts or glaucoma may require ophthalmology referral and re-evaluation of therapy.

πŸ‘οΈ

Symptom Monitoring

  • Worsening asthma symptoms (e.g., increased wheezing, shortness of breath, cough)
  • Increased need for rescue inhaler
  • Oral candidiasis (white patches in mouth or throat)
  • Signs of systemic corticosteroid effects (e.g., easy bruising, moon face, weight gain, fatigue, weakness) - rare with inhaled doses
  • Blurred vision or eye pain (potential for glaucoma/cataracts with long-term use)

Special Patient Groups

🀰

Pregnancy

Available data from published epidemiologic studies and postmarketing experience with fluticasone furoate use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. Asthma control is important during pregnancy. Use only if the potential benefit justifies the potential risk to the fetus.

Trimester-Specific Risks:

First Trimester: No increased risk of major birth defects observed in human studies.
Second Trimester: No specific risks identified.
Third Trimester: No specific risks identified.
🀱

Lactation

There are no available data on the presence of fluticasone furoate in human milk, the effects on the breastfed infant, or the effects on milk production. Other corticosteroids are present in human milk. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Arnuity Ellipta and any potential adverse effects on the breastfed infant from Arnuity Ellipta or from the underlying maternal condition.

Infant Risk: Low risk due to low systemic absorption of fluticasone furoate, making infant exposure via breast milk unlikely to be significant.
πŸ‘Ά

Pediatric Use

Safety and effectiveness for asthma have been established in children aged 5 years and older. Monitor growth velocity in pediatric patients receiving inhaled corticosteroids, as they may cause a reduction in growth velocity. The lowest effective dose should be used.

πŸ‘΄

Geriatric Use

No dosage adjustment is required based on age. Clinical studies did not identify differences in safety or effectiveness between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Arnuity Ellipta is a once-daily inhaled corticosteroid for maintenance treatment of asthma; it is NOT a rescue inhaler for acute bronchospasm.
  • Patients should be instructed on proper inhaler technique and to rinse their mouth with water and spit after each dose to minimize the risk of oral candidiasis.
  • Regular, consistent use is crucial for optimal asthma control. Patients should not stop therapy abruptly.
  • Monitor pediatric patients for growth velocity, as inhaled corticosteroids can affect growth.
  • Be aware of potential drug interactions with strong CYP3A4 inhibitors, which can increase systemic corticosteroid exposure.
πŸ”„

Alternative Therapies

  • Other inhaled corticosteroids (ICS): Fluticasone propionate (Flovent HFA, Flovent Diskus), Budesonide (Pulmicort Flexhaler), Mometasone (Asmanex Twisthaler), Beclomethasone (Qvar RediHaler), Ciclesonide (Alvesco).
  • ICS/LABA combinations (for patients not adequately controlled on ICS alone): Fluticasone furoate/Vilanterol (Breo Ellipta), Fluticasone propionate/Salmeterol (Advair Diskus/HFA), Budesonide/Formoterol (Symbicort), Mometasone/Formoterol (Dulera).
πŸ’°

Cost & Coverage

Average Cost: Varies widely, typically $200-$400+ per 14-dose inhaler
Insurance Coverage: Tier 2 or Tier 3 (Brand-name prescription)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe and effective treatment, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the amount, and the time it occurred.